Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Last data update: Sep 29, 2022. (Total: 49737 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 25405 Records)

Next

Query Trace: all[original query]>>Original Studies[Product Type]
Drug genetic associations with COVID-19 manifestations: a data mining and network biology approach
D Charitou et al, J PGX Journal, September 29, 2022
Knowledge and Attitudes about Privacy and Secondary Data Use among African-Americans Using Direct-to-Consumer Genetic Testing.
Ziegler Emily et al. Public health genomics 2022 1-10
Clinical Implementation of Combined Monogenic and Polygenic Risk Disclosure for Coronary Artery Disease.
Maamari Dimitri J et al. JACC advances 2022 1(3)
The KIDNEYCODE Program: Diagnostic Yield and Clinical Features of Individuals with CKD.
Lieberman Kenneth V et al. Kidney360 2022 3(5) 900-909
Landscape of EGFR mutations in lung adenocarcinoma: a single institute experience with comparison of PANAMutyper testing and targeted next-generation sequencing.
Lee Jeonghyo et al. Journal of pathology and translational medicine 2022 56(5) 249-259
GenOtoScope: Towards automating ACMG classification of variants associated with congenital hearing loss.
Melidis Damianos P et al. PLoS computational biology 2022 18(9) e1009785
Developing an Online Dashboard to Visualize Performance Data-Tennessee Newborn Screening Experience.
Lechner Charles et al. International journal of neonatal screening 2022 8(3)
Somatic tumor mutations in moderate risk cancer genes: Targets for germline confirmatory testing.
Llorin Hannah et al. Cancer genetics 2022 268-26922-27
Awareness and use of genetic testing: An analysis of the Health Information National Trends Survey 2020.
Tiner Jessica C et al. Genetics in medicine : official journal of the American College of Medical Genetics 2022
Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.
Whitworth Pat W et al. JAMA network open 2022 5(9) e2232787
Prevalence and Phenotypic Burden of Monogenic Arrhythmias Using Integration of Electronic Health Records With Genetics.
Nafissi Navid A et al. Circulation. Genomic and precision medicine 2022 101161CIRCGEN121003675
Does the 21-gene recurrence score have clinical utility in HR+/HER2+ breast cancer?
Bilani Nadeem et al. Breast (Edinburgh, Scotland) 2022 6649-53
Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases.
Lakeman Inge M M et al. Journal of medical genetics 2022
Breast cancer polygenic risk scores are associated with short-term risk of poor prognosis breast cancer.
McCarthy Anne Marie et al. Breast cancer research and treatment 2022
Combined Focused Next-Generation Sequencing Assays to Guide Precision Oncology in Solid Tumors: A Retrospective Analysis from an Institutional Molecular Tumor Board.
Tarawneh Thomas S et al. Cancers 2022 14(18)
Circulating Methylated SEPT9 DNA Analyses to Predict Recurrence Risk and Adjuvant Chemotherapy Benefit in Stage II to III Colorectal Cancer.
Yuan Zhen et al. Medical science monitor : international medical journal of experimental and clinical research 2022 28e937757
Implementation and outcome evaluations of a multi-site improvement program in cancer genetics.
Bednar Erica M et al. Journal of genetic counseling 2022
The Benefits of Family Screening in Rare Diseases: Genetic Testing Reveals 165 New Cases of Fabry Disease among At-Risk Family Members of 83 Index Patients.
Moiseev Sergey et al. Genes 2022 13(9)
Analysis of rare disruptive germline mutations in 2,135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes.
Loveday C et al. Annals of oncology : official journal of the European Society for Medical Oncology 2022
Development and Validation of the Minnesota Assessment of Pharmacogenomic Literacy (MAPL).
Allen Josiah D et al. Journal of personalized medicine 2022 12(9)
Landscape of Secondary Findings in Chinese Population: A Practice of ACMG SF v3.0 List.
Huang Yingzhao et al. Journal of personalized medicine 2022 12(9)
Understanding the Patient Experience of Receiving Clinically Actionable Genetic Results from the MyCode Community Health Initiative, a Population-Based Genomic Screening Initiative.
Baker Anna et al. Journal of personalized medicine 2022 12(9)
Effect of comprehensive cancer genomic profiling on therapeutic strategies and clinical outcomes in patients with advanced biliary tract cancer: A prospective multicenter study.
Takada Kohichi et al. Frontiers in oncology 2022 12988527
High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations.
Sturchio Andrea et al. Journal of Alzheimer's disease : JAD 2022
Ultrasonography screening in children and adolescents who have one parent with familial non-medullary thyroid carcinoma.
Rosario Pedro W et al. Journal of paediatrics and child health 2022
Usefulness of Genetic Aberration and Shorter Telomere Length in Myelodysplastic Syndrome: A Pilot Study.
Park Hee Sue et al. Laboratory medicine 2022
Differences in Prostate Cancer Transcriptomes by Age at Diagnosis: Are Primary Tumors from Older Men Inherently Different?
Zhou Charlie D et al. Cancer prevention research (Philadelphia, Pa.) 2022 OF1-OF11
Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer.
Vliek Sonja B et al. European journal of cancer (Oxford, England : 1990) 2022 175169-179
Prevalence and Treatment of Familial Hypercholesterolemia and Severe Hypercholesterolemia in Older Adults in Ontario, Canada.
Akioyamen Leo E et al. CJC open 2022 4(9) 739-747
Assessing Oncologists' Adoption of Biomarker Testing in Metastatic Colorectal Cancer Using Real World Data.
Iyer Pritish et al. JNCI cancer spectrum 2022
TOP